Valley is aware of the nationwide supply disruption of IV fluid solution due to Hurricane Helene, and wants to reassure the community that steps have been taken to ensure the situation will have no negative impact on our patients and the community.
The overall objective of CONFIRM2 is to perform the largest cardiovascular phenotype outcomes study ever.
NCT04279496